The Role of Stem Cells on Immune Cells in the Development of Cardiovascular Diseases
The Role of Stem Cells on Immune Cells in the Development of Cardiovascular Diseases
An observational pilot proof-of-principle study. 15 patients with significant coronary artery
 disease and 15 matched controls. To investigate whether long-term activation of the innate
 immune system, named 'trained innate immunity', occurs at the level of the bone marrow
 progenitor cells in patients with significant coronary artery disease and whether this
 correlates with the proinflammatory phenotype of monocytes.
Inclusion Criteria:

 -  Age ≥18 and ≤75 years

 -  With or without significant coronary artery disease on CCTA

 -  Written informed consent

 Exclusion Criteria:

 -  Chronic infections

 -  Diabetes mellitus

 -  Medical history of any disease associated with immune deficiency

 -  Clinically significant infections within 3 months prior to study entry

 -  Recent hospital admission or surgery with general anaesthesia

 -  Known chronic kidney or liver disease

 -  Previous vaccination within 3 months prior to study entry

 -  Inability to personally provide written informed consent

 -  Inability to undergo PET-CT scanning

 -  Chronic use of anti-inflammatory drugs such as NSAIDs

 -  History of haematological malignant disease

 -  Documented bleeding diathesis or thrombocytopenia

 -  Pregnancy